Mikhail Krasavin Selected Research

Iron Overload

2/2019	Facile Access to Fe(III)-Complexing Cyclic Hydroxamic Acids in a Three-Component Format.
12/2017	Cyclic Hydroxamic Acid Analogues of Bacterial Siderophores as Iron-Complexing Agents prepared through the Castagnoli-Cushman Reaction of Unprotected Oximes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikhail Krasavin Research Topics

Disease

24	Neoplasms (Cancer) 01/2023 - 12/2016
5	Glaucoma 01/2023 - 01/2016
4	Type 2 Diabetes Mellitus (MODY) 04/2021 - 01/2016
3	Neuralgia (Stump Neuralgia) 12/2021 - 01/2016
2	Psychotic Disorders (Schizoaffective Disorder) 11/2022 - 09/2022
2	Mental Disorders (Mental Disorder) 11/2022 - 01/2017
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021 - 09/2018
2	Hypoxia (Hypoxemia) 12/2020 - 02/2019
2	Iron Overload 02/2019 - 12/2017
2	Edema (Dropsy) 01/2016 - 09/2014
1	Body Weight (Weight, Body) 02/2023
1	Insulin Resistance 02/2023
1	Hyperinsulinism (Hyperinsulinemia) 02/2023
1	Multiple Myeloma 01/2023
1	Bacterial Infections (Bacterial Infection) 01/2023
1	Schizophrenia (Dementia Praecox) 11/2022
1	Adenocarcinoma of Lung 01/2022
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2021
1	autosomal dominant Spastic paraplegia 6 10/2021
1	Insulinoma 04/2021
1	Arthritis (Polyarthritis) 12/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020
1	Glioblastoma (Glioblastoma Multiforme) 04/2020
1	Glioma (Gliomas) 01/2020
1	Communicable Diseases (Infectious Diseases) 04/2019
1	Adenocarcinoma 04/2019
1	Human Influenza (Influenza) 01/2019
1	Rheumatoid Arthritis 01/2019

Drug/Important Bio-Agent (IBA)

16	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2016
13	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2023 - 01/2016
8	SulfonamidesIBA 01/2023 - 01/2016
5	Thioredoxin-Disulfide ReductaseIBA 06/2021 - 01/2020
4	EnzymesIBA 01/2022 - 04/2019
3	Carbonic Anhydrase InhibitorsIBA 12/2022 - 01/2017
3	Carbonic Anhydrase IXIBA 12/2021 - 04/2019
3	Nonesterified Fatty Acids (NEFA)IBA 04/2021 - 01/2016
3	BenzenesulfonamidesIBA 11/2019 - 10/2017
3	ImidazolinesIBA 04/2019 - 10/2017
2	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 04/2021
2	Trace amine-associated receptor 1IBA 11/2022 - 09/2022
2	AminesIBA 11/2022 - 11/2016
2	ThioredoxinsIBA 01/2022 - 01/2020
2	CoumarinsIBA 12/2021 - 10/2021
2	CaspasesIBA 12/2021 - 10/2021
2	BenzopyransIBA 12/2021 - 10/2021
2	AnhydridesIBA 12/2021 - 01/2018
2	IsoenzymesIBA 06/2021 - 12/2020
2	SelenocysteineIBA 06/2021 - 11/2019
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2020 - 01/2020
2	Carbonic Anhydrase IIIBA 11/2019 - 01/2017
2	LY2881835IBA 12/2017 - 11/2016
2	Metabotropic Glutamate 5 ReceptorIBA 06/2017 - 01/2017
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2016 - 01/2016
1	LeptinIBA 02/2023
1	Insulin (Novolin)FDA Link 02/2023
1	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 02/2023
1	SulfurIBA 01/2023
1	SulfonesIBA 01/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	pyrazoleIBA 01/2023
1	1H-tetrazole (tetrazole)IBA 01/2023
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 11/2022
1	diphenyl (biphenyl)IBA 11/2022
1	Cytostatic AgentsIBA 01/2022
1	Free RadicalsIBA 01/2022
1	Cytotoxins (Cytolysins)IBA 01/2022
1	NitrogenIBA 01/2022
1	AntioxidantsIBA 01/2022
1	Drug CombinationsIBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	ZincIBA 12/2021
1	ammonium acetateIBA 12/2021
1	NucleosidesIBA 12/2021
1	elsulfavirineIBA 12/2021
1	ProdrugsIBA 12/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2021
1	Reverse Transcriptase InhibitorsIBA 12/2021
1	Caspase 3 (Caspase-3)IBA 10/2021
1	coumarinIBA 10/2021
1	TAK-875IBA 04/2021
1	PiperidinesIBA 04/2021
1	pretomanidIBA 01/2021
1	OPC-67683IBA 01/2021
1	NitroimidazolesIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 12/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019
1	DNA (Deoxyribonucleic Acid)IBA 12/2019
1	Thioredoxin Reductase 1IBA 11/2019
1	Benzene (Benzole)IBA 04/2019
1	pyridazineIBA 04/2019
1	OxadiazolesIBA 04/2019
1	Monoamine Oxidase (MAO)IBA 04/2019
1	IronIBA 02/2019
1	Hydroxamic Acids (Hydroxamic Acid)IBA 02/2019

Therapy/Procedure

6	Therapeutics 01/2022 - 12/2017
4	Drug Therapy (Chemotherapy) 11/2022 - 01/2017
1	Induced Hyperthermia (Thermotherapy) 11/2022